Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
10x Genomics Inc (TXG)
NASDAQ:TXG
10x Genomics (TXG) Stock Price & Analysis
613 Followers
TXG Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$23.81 - $100.00
Previous Close$48.65
Volume696.68K
Average Volume (3M)1.35M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$452.39M
Total Debt (Recent Filing)$96.23M
Price to Earnings (P/E)-33.0
Beta1.82
Next EarningsFeb 15, 2023
EPS Estimate-$0.29
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$54.80
EPS (TTM)-1.48
Shares Outstanding114,463,521
R-Squared0.36
Standard Deviation0.16
10 Day Avg. Volume1,423,037
30 Day Avg. Volume1,349,896
Price to Book (P/B)6.89
Price to Sales (P/S)12.56
Price to Cash Flow (P/CF)199.90
P/FCF Ratio-36.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside12.64% Upside
Rating ConsensusStrong Buy
Alpha-0.00849
Number of Analyst Covering5
10x Genomics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TXG FAQ
What was 10x Genomics’s price range in the past 12 months?
10x Genomics lowest stock price was $23.81 and its highest was $100.00 in the past 12 months.
What is 10x Genomics’s market cap?
Currently, no data Available
When is 10x Genomics’s upcoming earnings report date?
10x Genomics’s upcoming earnings report date is Feb 15, 2023 which is in 18 days.
How were 10x Genomics’s earnings last quarter?
10x Genomics released its earnings results on Nov 02, 2022. The company reported -$0.37 earnings per share for the quarter, beating the consensus estimate of -$0.467 by $0.097.
Is 10x Genomics overvalued?
According to Wall Street analysts 10x Genomics’s price is currently Undervalued.
Does 10x Genomics pay dividends?
10x Genomics does not currently pay dividends.
What is 10x Genomics’s EPS estimate?
10x Genomics’s EPS estimate is -$0.29.
How many shares outstanding does 10x Genomics have?
10x Genomics has 95,596,270 shares outstanding.
What happened to 10x Genomics’s price movement after its last earnings report?
10x Genomics reported an EPS of -$0.37 in its last earnings report, beating expectations of -$0.467. Following the earnings report the stock price went up 18.499%.
Which hedge fund is a major shareholder of 10x Genomics?
Among the largest hedge funds holding 10x Genomics’s share is ARK Investment Management LLC. It holds 10x Genomics’s shares valued at 130M.
---
10x Genomics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$54.80
$54.80
Blogger Sentiment
Bearish
TXG Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 502.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $27.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.0%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-43.33%
12-Months-Change
Fundamentals
Return on Equity
-21.22%
Trailing 12-Months
Asset Growth
0.57%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
10x Genomics Inc
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA.
---
---